Page 28 - PULSE@UM
P. 28

innovation and technology






















                                   Fig. 3. First-generation nanotherapeutics.

        from the Nanotherapeutics Lab (NTL) has been progressing well in the development of new
        generation anticancer nanotherapeutics and nano-drug-carriers for active and passive tumour
        delivery  of anticancer  drugs and  imaging probes.  Some  of  the  notable  products  developed
        by the team  include  high-drug-payload nanotherapeutics, immuno-stealth-nanotherapeutics,
        free-radical-generating  near-Infrared (NIR)-photodynamic nanotherapeutics, photothermal
        nanotherapeutics, etc. Although good progress is seen in the nanotherapeutics research both
        from within UM and respective institutions across Malaysia, greater  investments  from the
        public and private sectors are still very much needed not just to further excite the growth of
        the field, but also to encourage coalition among the local research groups and companies for
        greater advancements.


        References:
        1.  McWilliams, A., Global Markets for Nanocomposites, Nanoparticles, Nanoclays, and Nanotubes. NAN021G,
            Global Markets, BBC Research Report Jan 2017.
        2.  Kiew, S. F.; Ho, Y. T.; Kiew, L. V.; Kah, J. C. Y.; Lee, H. B.; Imae, T.; Chung, L. Y., Preparation and characterization
            of an amylase-triggered dextrin-linked graphene  oxide anticancer  drug nanocarrier  and its vascular
            permeability. International Journal of Pharmaceutics 2017, 534 (1-2), 297-307.
        3.  Voon, S. H.; Tiew, S. X.; Kue, C. S.; Lee, H. B.; Kiew, L. V.; Misran, M.; Kamkaew, A.; Burgess, K.; Chung, L.
            Y., Chitosan-Coated  Poly(lactic-co-glycolic acid)-Diiodinated  Boron-Dipyrromethene  Nanoparticles
            Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy. Journal of Biomedical
            Nanotechnology 2016, 12 (7), 1431-1452.
        4.  Cheah, H. Y.; Gallon, E.; Dumoulin, F.; Hoe, S. Z.; Japundžić-Žigon, N.; Glumac, S.; Lee, H. B.; Anand, P.; Chung,
            L. Y.; Vicent, M. J.; Kiew, L. V., Near-Infrared Activatable Phthalocyanine–Poly-L-Glutamic Acid Conjugate:
            Enhanced  in  Vivo  Safety  and  Antitumor  Efficacy  toward  an  Effective  Photodynamic  Cancer  Therapy.
            Molecular pharmaceutics 2018, 15 (7), 2594-2605.
        5.  Saw, W. S.; Ujihara, M.; Chong, W. Y.; Voon, S. H.; Imae, T.; Kiew, L. V.; Lee, H. B.; Sim, K. S.; Chung, L. Y.,
            Size-dependent effect of cystine/citric acid-capped confeito-like gold nanoparticles on cellular uptake and
            photothermal cancer therapy. Colloids and surfaces. B, Biointerfaces 2018, 161, 365-374.

    28
   23   24   25   26   27   28   29   30   31   32   33